| CTRI Number |
CTRI/2025/09/094533 [Registered on: 10/09/2025] Trial Registered Prospectively |
| Last Modified On: |
10/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Comparision of local anesthetics with and without adjuvant in transversus abdominis plane block for postoperative pain relief in infants . |
|
Scientific Title of Study
|
To compare injection bupivacaine(0.75mg/kg) and injection bupivacaine (0.5mg/kg)+ injection lignocaine (2mg/kg) in transversus abdominis plane block for postoperative analgesia in infants undergoing abdominal surgery. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Shreya M S |
| Designation |
junior resident 2 |
| Affiliation |
Sapthagiri Institute Of Medical Sciences And Research Centre |
| Address |
sapthagiri institute of medical science and research centre
deptarment of anesthesia
hesargatta
banglore ,karnataka-560090
Bangalore KARNATAKA 560090 India |
| Phone |
09483679128 |
| Fax |
|
| Email |
77shreya@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Prashanthprabhu J |
| Designation |
professor in department of anesthesiology |
| Affiliation |
Sapthagiri Institute Of Medical Sciences And Research Centre |
| Address |
sapthagiri institute of medical science and research centre
deptarment of anesthesia
hesargatta
banglore ,karnataka-560090
Bangalore KARNATAKA 560090 India |
| Phone |
9035067161 |
| Fax |
|
| Email |
prashanthjnpl@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Prashanthprabhu J |
| Designation |
professor in department of anesthesiology |
| Affiliation |
Sapthagiri Institute Of Medical Sciences And Research Centre |
| Address |
sapthagiri institute of medical science and research centre
deptarment of anesthesia
hesargatta
banglore ,karnataka-560090
Bangalore KARNATAKA 560090 India |
| Phone |
9035067161 |
| Fax |
|
| Email |
prashanthjnpl@gmail.com |
|
|
Source of Monetary or Material Support
|
| sapthagiri institute of medical science and research centre |
|
|
Primary Sponsor
|
| Name |
Sapthagiri Institute of Medical Science and Research Center |
| Address |
15, Hesarghatta Rd, Navy Layout, Chikkasandra, Chikkabanavara, Bengaluru, Karnataka 560090 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shreya M S |
Sapthagiri hospital |
sapthagiri institute of medical science and research centre
department of anesthesiology
OT number 10
4th floor super-speciality building
hesargatta road
navy layout
banglore-560090
Bangalore KARNATAKA |
09483679128
77shreya@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Sapthagiri institute of medical sciences and research center |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: R52||Pain, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Bupivacaine 0.5 mg per kg with Lignocaine 1 mg per kg |
Combination of Bupivacaine 0.5 mg per kg and Lignocaine 1 mg per kg administered as a surgeon performed Transversus Abdominis Plane block under aseptic precautions at the end of surgery. |
| Intervention |
Bupivacaine 0.75 mg per kg |
Bupivacaine 0.75 mg per kg ,for Transversus Abdominis Plane block under aseptic precautions at the end of surgery by surgeon |
|
|
Inclusion Criteria
|
| Age From |
1.00 Day(s) |
| Age To |
12.00 Month(s) |
| Gender |
Both |
| Details |
Infants aged from birth to 12 months undergoing abdominal surgery.
ASA physical status I and II.
Parents or guardians willing to provide informed written consent. |
|
| ExclusionCriteria |
| Details |
Local infection at the block site.
Known hypersensitivity or allergy to bupivacaine or lignocaine. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| postoperative analgesia using Neonatal Infant Pain Scale (NIPS) and total rescue analgesic requirement within 24 hours after surgery. |
24hours |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="54" Sample Size from India="54"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
24/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="8" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
A prospective randomized controlled study comparing injection bupivacaine 0.75 mg per kg with injection bupivacaine 0.5 mg per kg plus injection lignocaine 2 mg per kg for postoperative analgesia in surgeon-administered Transversus Abdominis Plane block in infants undergoing abdominal surgery. .The primary outcome is to compare postoperative pain scores using NIPS and total rescue analgesic requirement within 24 hours. This trial is registered to promote safe and effective pain management strategies in infants undergoing surgery. |